Apexigen
About:
Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.
Website: http://www.apexigen.com
Top Investors: Delian Capital, Decheng Capital, 3E Bioventures, SV Tech Ventures, Oceanpine Capital
Description:
Apexigen is a clinical-stage biopharmaceutical company developing antibody therapeutics for the treatment of cancer. It specializes in new immuno-oncology products designed to harness the patient’s immune system to combat and eradicate cancer.
Total Funding Amount:
$176M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Carlos, California, United States
Founded Date:
2010-01-01
Contact Email:
info(AT)apexigen.com
Founders:
Xiaodong Yang
Number of Employees:
11-50
Last Funding Date:
2023-01-24
IPO Status:
Delisted
Industries:
© 2025 bioDAO.ai